CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenue	$ 490.2	$ 443.7	$ 951.6	$ 875.4
Cost of revenue	259.8	238.5	506.5	470.8
Gross profit	230.4	205.2	445.1	404.6
Operating expenses:
Selling, general and administrative	124.5	110.6	244.6	220.9
Research and development	48.5	43.6	94.9	86.8
Other charges, net	3.9	2.2	10.2	10.0
Total operating expenses	176.9	156.4	349.7	317.7
Operating income	53.5	48.8	95.4	86.9
Interest and other income (expense), net	(5.9)	(5.5)	(9.4)	(7.8)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	47.6	43.3	86.0	79.1
Income tax provision	10.6	11.8	18.3	20.2
Consolidated net income	37.0	31.5	67.7	58.9
Net income attributable to noncontrolling interests in consolidated subsidiaries	0.5	0.3	0.4	0.7
Net income attributable to Bruker Corporation	$ 36.5	$ 31.2	$ 67.3	$ 58.2
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.23	$ 0.20	$ 0.43	$ 0.37
Diluted (in dollars per share)	$ 0.23	$ 0.20	$ 0.43	$ 0.37
Weighted average common shares outstanding:
Basic (in shares)	156.1	156.1	156.4	156.0
Diluted (in shares)	157.6	157.0	157.7	157.0
Comprehensive income (loss)	$ 49.5	$ (5.4)	$ 65.9	$ 46.4
Less: Comprehensive income (loss) attributable to noncontrolling interests	0.9	(0.2)	0.8	0.4
Less: Comprehensive income (loss) attributable to redeemable noncontrolling interest			(0.6)
Comprehensive income (loss) attributable to Bruker Corporation	$ 48.6	$ (5.2)	$ 65.7	$ 46.0
Dividend declared per common share (in dollars per share)	$ 0.04	$ 0.04	$ 0.08	$ 0.08
Product
Revenue	$ 411.7	$ 368.1	$ 794.7	$ 720.3
Cost of revenue	210.0	188.7	407.5	374.3
Service
Revenue	78.5	73.5	155.9	151.2
Cost of revenue	$ 49.8	49.1	98.9	95.6
Other
Revenue		2.1	1.0	3.9
Cost of revenue		$ 0.7	$ 0.1	$ 0.9